📰 Pediatric Eoe News
Pediatric Eoe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pediatric Eoe. Real-time updates on events, politics, business and more.
January 30, 2024
Findings from the trial showed that a significantly greater proportion of patients treated with dupilumab met the primary endpoint achieving significant histological disease remission.
January 26, 2024
The expanded indication makes dupilumab the only approved treatment for eosinophilic esophagitis (EoE) in this age group.
January 26, 2024
Dupilumab is now indicated for the treatment of eosinophilic esophagitis in children as young as 1 year and weighing at least 15 kg.
January 26, 2024
Findings from the trial showed that a significantly greater proportion of patients treated with dupilumab met the primary endpoint achieving significant histological disease remission.
January 25, 2024
Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo Expanded indication marks second disease for...
January 25, 2024
Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis Approval based on Phase 3 EoE KIDS trial showing a greater...
January 25, 2024
Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo Expanded indication marks second disease for...